Markers of HTLV-III in patients with end stage renal failure treated by haemodialysis.
- 19 July 1986
- Vol. 293 (6540), 161-162
- https://doi.org/10.1136/bmj.293.6540.161
Abstract
Patients and members of staff from a haemodialysis unit were tested for markers of infection with human T cell lymphotropic virus type III (HTLV-III), the virus associated with the acquired immune deficiency syndrome (AIDS). An enzyme linked immunosorbent assay showed eight of 100 patients to have antibodies to HTLV-III. In five of these patients past or present infection with HTLV-III was confirmed by Western blot analysis or detection of HTLV-III antigens in lymphocyte cultures, or both. Investigation of other risk factors for AIDS showed that the putative source of HTLV-III was unrelated to dialysis in two patients whereas blood transfusion was the most likely cause of contamination in the others. No member of staff gave a positive result in the enzyme linked immunosorbent assay. Nosocomial transmission of HTLV-III seems unlikely if precautions similar to those recommended for the control of hepatitis B infection are applied.This publication has 7 references indexed in Scilit:
- HTLV-III ANTIBODIES IN PATIENTS WITH KIDNEY TRANSPLANTS OR ON HAEMODIALYSISThe Lancet, 1986
- Recommended Precautions for Patients Undergoing Hemodialysis Who Have AIDS or Non-A, Non-B HepatitisInfection Control, 1985
- Transfusion-Associated Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1985
- Development and early natural history of HTLV-III antibodies in persons with hemophiliaJAMA, 1985
- Bovine Leukemia Virus-Related Antigens in Lymphocyte Cultures Infected with AIDS-Associated VirusesScience, 1985